408 related articles for article (PubMed ID: 9241108)
21. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia.
Smego RA; Nagar S; Maloba B; Popara M
Arch Intern Med; 2001 Jun; 161(12):1529-33. PubMed ID: 11427101
[TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy and safety of Pneumocystis jirovecii pneumonia prophylaxis regimens for people living with HIV: a systematic review and network meta-analysis of randomized controlled trials.
Prosty C; Katergi K; Sorin M; Rjeily MB; Butler-Laporte G; McDonald EG; Lee TC
Clin Microbiol Infect; 2024 Jul; 30(7):866-876. PubMed ID: 38583518
[TBL] [Abstract][Full Text] [Related]
23. Dapsone/pyrimethamine versus aerosolized pentamidine as prophylaxis against PCP in HIV infection.
Dorrell L; McCallum AK; Snow MH; Ong EL
AIDS Patient Care; 1995 Oct; 9(5):224-8. PubMed ID: 11361401
[No Abstract] [Full Text] [Related]
24. Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus.
Simonds RJ; Hughes WT; Feinberg J; Navin TR
Clin Infect Dis; 1995 Aug; 21 Suppl 1():S44-8. PubMed ID: 8547511
[TBL] [Abstract][Full Text] [Related]
25. Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immune deficiency syndrome.
Montgomery AB; Feigal DW; Sattler F; Mason GR; Catanzaro A; Edison R; Markowitz N; Johnson E; Ogawa S; Rovzar M
Am J Respir Crit Care Med; 1995 Apr; 151(4):1068-74. PubMed ID: 7697233
[TBL] [Abstract][Full Text] [Related]
26. [Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer].
Groll AH; Ritter J; Müller FM
Klin Padiatr; 2001 Sep; 213 Suppl 1():A38-49. PubMed ID: 11577363
[TBL] [Abstract][Full Text] [Related]
27. Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.
Hughes WT
Antimicrob Agents Chemother; 1988 May; 32(5):623-5. PubMed ID: 3260765
[TBL] [Abstract][Full Text] [Related]
28. Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis.
Freedberg KA; Tosteson AN; Cohen CJ; Cotton DJ
J Acquir Immune Defic Syndr (1988); 1991; 4(5):521-31. PubMed ID: 1673157
[TBL] [Abstract][Full Text] [Related]
29. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
Korraa H; Saadeh C
South Med J; 1996 Mar; 89(3):272-7. PubMed ID: 8604455
[TBL] [Abstract][Full Text] [Related]
30. A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS.
Payen MC; De Wit S; Sommereijns B; Clumeck N
Biomed Pharmacother; 1997; 51(10):439-45. PubMed ID: 9863502
[TBL] [Abstract][Full Text] [Related]
31. Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial.
Murri R; Ammassari A; Pezzotti P; Cingolani A; De Luca A; Pallavicini F; Grillo R; Antinori A
J Acquir Immune Defic Syndr; 2001 May; 27(1):49-55. PubMed ID: 11404520
[TBL] [Abstract][Full Text] [Related]
32. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB
N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131
[TBL] [Abstract][Full Text] [Related]
33. [Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994].
Bossi P; Caumes E; Astagneau P; Li TS; Paris L; Mengual X; Katlama C; Bricaire F
Rev Med Interne; 1998 May; 19(5):313-7. PubMed ID: 9775164
[TBL] [Abstract][Full Text] [Related]
34. Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV.
Drug Ther Bull; 1994 Feb; 32(2):12-5. PubMed ID: 7654282
[TBL] [Abstract][Full Text] [Related]
35. Pneumocystis carinii pneumonia prophylaxis during pregnancy.
Connelly RT; Lourwood DL
Pharmacotherapy; 1994; 14(4):424-9. PubMed ID: 7937279
[TBL] [Abstract][Full Text] [Related]
36. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR
Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948
[TBL] [Abstract][Full Text] [Related]
37. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review.
Hughes WT
Clin Infect Dis; 1998 Jul; 27(1):191-204. PubMed ID: 9675476
[TBL] [Abstract][Full Text] [Related]
38. Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
Mallolas J; Zamora L; Gatell JM; Miró JM; Soriano E
Lancet; 1991 May; 337(8750):1162-3. PubMed ID: 1674036
[No Abstract] [Full Text] [Related]
39. Bacterial infections in adult patients hospitalized with AIDS: case-control study of prophylactic efficacy of trimethoprim-sulfamethoxazole versus aerosolized pentamidine.
Tabet SR; Krone MR; Hooton TM; Koutsky LA; Holmes KK
Int J STD AIDS; 1997 Sep; 8(9):563-9. PubMed ID: 9292345
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Pneumocystis carinii pneumonia in adults with AIDS.
Deresinski SC
Semin Respir Infect; 1997 Jun; 12(2):79-97. PubMed ID: 9195673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
